Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.34
BONE's Cash to Debt is ranked higher than
53% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. BONE: 0.34 )
BONE' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 0.34

Equity to Asset -0.14
BONE's Equity to Asset is ranked lower than
54% of the 446 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. BONE: -0.14 )
BONE' s 10-Year Equity to Asset Range
Min: -0.28   Max: 0.85
Current: -0.14

-0.28
0.85
F-Score: 4
Z-Score: -1.70
M-Score: -3.65
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -21.25
BONE's Operating margin (%) is ranked higher than
58% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 5.91 vs. BONE: -21.25 )
BONE' s 10-Year Operating margin (%) Range
Min: -55.87   Max: -3.49
Current: -21.25

-55.87
-3.49
Net-margin (%) -32.95
BONE's Net-margin (%) is ranked higher than
57% of the 459 Companies
in the Global Medical Devices industry.

( Industry Median: 4.15 vs. BONE: -32.95 )
BONE' s 10-Year Net-margin (%) Range
Min: -126.27   Max: -3.49
Current: -32.95

-126.27
-3.49
ROE (%) -6509.23
BONE's ROE (%) is ranked lower than
57% of the 443 Companies
in the Global Medical Devices industry.

( Industry Median: 5.20 vs. BONE: -6509.23 )
BONE' s 10-Year ROE (%) Range
Min: -6509.23   Max: -123.15
Current: -6509.23

-6509.23
-123.15
ROA (%) -37.55
BONE's ROA (%) is ranked higher than
55% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.77 vs. BONE: -37.55 )
BONE' s 10-Year ROA (%) Range
Min: -148.33   Max: -15.44
Current: -37.55

-148.33
-15.44
ROC (Joel Greenblatt) (%) -60.03
BONE's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 9.15 vs. BONE: -60.03 )
BONE' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -152.2   Max: -35.66
Current: -60.03

-152.2
-35.66
Revenue Growth (3Y)(%) 13.30
BONE's Revenue Growth (3Y)(%) is ranked higher than
88% of the 340 Companies
in the Global Medical Devices industry.

( Industry Median: 5.00 vs. BONE: 13.30 )
BONE' s 10-Year Revenue Growth (3Y)(%) Range
Min: 0   Max: 40.7
Current: 13.3

0
40.7
EBITDA Growth (3Y)(%) -34.00
BONE's EBITDA Growth (3Y)(%) is ranked higher than
58% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.60 vs. BONE: -34.00 )
BONE' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 2.7
Current: -34

0
2.7
EPS Growth (3Y)(%) -23.90
BONE's EPS Growth (3Y)(%) is ranked higher than
62% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.70 vs. BONE: -23.90 )
BONE' s 10-Year EPS Growth (3Y)(%) Range
Min: 0   Max: 5.3
Current: -23.9

0
5.3
» BONE's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with BONE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 0.40
BONE's P/S is ranked higher than
97% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 3.57 vs. BONE: 0.40 )
BONE' s 10-Year P/S Range
Min: 0.4   Max: 20.1
Current: 0.4

0.4
20.1
EV-to-EBIT -4.15
BONE's EV-to-EBIT is ranked lower than
59% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 61.55 vs. BONE: -4.15 )
BONE' s 10-Year EV-to-EBIT Range
Min: -47.8   Max: -3.6
Current: -4.15

-47.8
-3.6
Current Ratio 2.47
BONE's Current Ratio is ranked higher than
69% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.79 vs. BONE: 2.47 )
BONE' s 10-Year Current Ratio Range
Min: 0.74   Max: 6.87
Current: 2.47

0.74
6.87
Quick Ratio 1.29
BONE's Quick Ratio is ranked higher than
59% of the 467 Companies
in the Global Medical Devices industry.

( Industry Median: 2.01 vs. BONE: 1.29 )
BONE' s 10-Year Quick Ratio Range
Min: 0.29   Max: 4.93
Current: 1.29

0.29
4.93

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.24
BONE's Price/Median PS Value is ranked higher than
98% of the 510 Companies
in the Global Medical Devices industry.

( Industry Median: 1.21 vs. BONE: 0.24 )
BONE' s 10-Year Price/Median PS Value Range
Min: 0.34   Max: 11.32
Current: 0.24

0.34
11.32
Earnings Yield (Greenblatt) -24.10
BONE's Earnings Yield (Greenblatt) is ranked lower than
51% of the 469 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. BONE: -24.10 )
BONE' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0   Max: 0
Current: -24.1

Business Description

Industry: Medical Devices » Medical Devices
Compare: » details
Bacterin International Holdings, Inc., develops, manufactures, and markets biologics products. The Company's products are used in various applications, including enhancing fusion in spine surgery, relief of back pain with a facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing, and subcondral bone defect repair in knee and other joint surgeries. The Company's medical devices division develops coatings for medical devices and custom surgical instruments for use with allografts processed by its biologics division. Its medical devices division also works with its biologics division to produce and distribute OsteoSelect DBM putty, an osteoinductive product used by surgeons as a bone void filler in the extremities and pelvis. The Company's main competitors in the orthopedic biomaterials markets include: Medtronic, DePuy/Synthes, Arthrex, Smith & Nephew, Nuvasive, OrthoFix, Biomet, MTF, Stryker, RTI Surgical, AlloSource, Lifenet Health, Integra, ConMed/Linvatec, Wright Medical, Exactech, KCI, Baxter and Alphatec. It is registered with the FDA as a manufacturer of human cellular and tissue products (HCT/Ps) as well as medical devices.
» More Articles for BONE

Headlines

Articles On GuruFocus.com
Weekly CFO Buys Highlight: GSVC, PSTB, BONE, ORIT May 09 2011 

More From Other Websites
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial... Nov 26 2014
Bacterin to Present at the 7th Annual LD Micro Conference Nov 26 2014
Bacterin to Present at the 7th Annual LD Micro Conference Nov 26 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Financials Nov 19 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial... Nov 17 2014
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference Nov 17 2014
Bacterin to Present at the Singular Research 9th Annual Best of the Uncovereds Conference Nov 17 2014
Bacterin Receives Delisting Notice From NYSE MKT Nov 14 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy... Nov 14 2014
Bacterin Receives Delisting Notice From NYSE MKT Nov 14 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial... Nov 12 2014
Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman Nov 11 2014
Bacterin CEO Dan Goldberger to be Guest on FOX Business Network's After the Bell with Liz Claman Nov 11 2014
10-Q for Bacterin International Holdings, Inc. Nov 09 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 10-Q, Quarterly Report Nov 07 2014
Bacterin Announces Third Quarter 2014 Results Nov 05 2014
BACTERIN INTERNATIONAL HOLDINGS, INC. Files SEC form 8-K, Results of Operations and Financial... Nov 05 2014
Bacterin Announces Third Quarter 2014 Results Nov 05 2014
Bacterin Announces Further Expansion of Its Sales Force Nov 05 2014
Bacterin Announces Further Expansion of Its Sales Force Nov 05 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK